Hart Allyson, Schladt David P, Zeglin Jessica, Pyke Joshua, Kim W Ray, Lake John R, Roberts John P, Hirose Ryutaro, Mulligan David C, Kasiske Bertram L, Snyder Jon J, Israni Ajay K
1 Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, MN. 2 Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN. 3 Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Palo Alto, CA. 4 Division of Gastroenterology, Department of Medicine, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN. 5 Department of Surgery, University of California San Francisco, San Francisco, CA. 6 Department of Surgery, Yale University, New Haven, CT. 7 Department of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN.
Transplantation. 2016 Oct;100(10):2153-9. doi: 10.1097/TP.0000000000001384.
The probability of liver transplant and death on the waiting list in the United States varies greatly by donation service area (DSA) due to geographic differences in availability of organs and allocation of priority points, making it difficult for providers to predict likely outcomes after listing. We aimed to develop an online calculator to report outcomes by region and patient characteristics.
Using the Scientific Registry of Transplant Recipients database, we included all prevalent US adults aged 18 years or older waitlisted for liver transplant, examined on 24 days at least 30 days apart over a 2-year period. Outcomes were determined at intervals of 30 to 365 days. Outcomes are reported by transplant program, DSA, region, and the nation for comparison, and can be shown by allocation or by laboratory model for end-stage liver disease (MELD) score (6-14, 15-24, 25-29, 30-34, 35-40), age, and blood type.
Outcomes varied greatly by DSA; for candidates with allocation MELD 25-29, the 25th and 75th percentiles of liver transplant probability were 30% and 67%, respectively, at 90 days. Corresponding percentiles for death or becoming too sick to undergo transplant were 5% and 9%. Outcomes also varied greatly for candidates with and without MELD exception points.
The waitlist outcome calculator highlights ongoing disparities in access to liver transplant and may assist providers in understanding and counseling their patients about likely outcomes on the waiting list.
在美国,由于器官供应和优先点数分配的地理差异,肝移植的概率以及在等待名单上死亡的概率在不同捐赠服务区(DSA)之间差异很大,这使得医疗服务提供者难以预测列入名单后的可能结果。我们旨在开发一个在线计算器,按地区和患者特征报告结果。
使用移植受者科学登记数据库,我们纳入了所有年龄在18岁及以上、在美国等待肝移植的成年患者,在两年期间内于至少间隔30天的24天进行检查。结果每隔30至365天确定一次。结果按移植项目、DSA、地区和全国进行报告以作比较,并可按分配情况或按终末期肝病模型(MELD)评分(6 - 14、15 - 24、25 - 29、30 - 34、35 - 40)、年龄和血型显示。
不同DSA的结果差异很大;对于分配MELD评分为25 - 29的候选人,90天时肝移植概率的第25和第75百分位数分别为30%和67%。死亡或病情过重无法进行移植的相应百分位数为5%和9%。有和没有MELD例外点数的候选人结果差异也很大。
等待名单结果计算器突出了肝移植可及性方面持续存在的差异,并可能有助于医疗服务提供者理解并向患者咨询其在等待名单上的可能结果。